These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11917131)

  • 1. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
    Staege MS; Lee SP; Frisan T; Mautner J; Scholz S; Pajic A; Rickinson AB; Masucci MG; Polack A; Bornkamm GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4550-5. PubMed ID: 11917131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-MYC impairs immunogenicity of human B cells.
    Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
    Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Floettmann JE; Ward K; Rickinson AB; Rowe M
    Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mucin (MUC-1) from a mini-Epstein-Barr virus in immortalized B-cells to generate tumor antigen specific cytotoxic T cells.
    Kilger E; Pecher G; Schwenk A; Hammerschmidt W
    J Gene Med; 1999; 1(2):84-92. PubMed ID: 10738572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
    Masucci MG; Klein E
    Semin Cancer Biol; 1991 Feb; 2(1):63-71. PubMed ID: 1655115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity (a short review).
    Klein G
    Acta Microbiol Immunol Hung; 1996; 43(2-3):97-105. PubMed ID: 8876725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Kelly G; Bell A; Rickinson A
    Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
    Khanna R; Burrows SR; Suhrbier A; Jacob CA; Griffin H; Misko IS; Sculley TB; Rowe M; Rickinson AB; Moss DJ
    J Immunol; 1993 Jun; 150(11):5154-62. PubMed ID: 7684421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells.
    Pajic A; Staege MS; Dudziak D; Schuhmacher M; Spitkovsky D; Eissner G; Brielmeier M; Polack A; Bornkamm GW
    Int J Cancer; 2001 Sep; 93(6):810-6. PubMed ID: 11519042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
    Klein G; Klein E; Kashuba E
    Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H1, which represses EBV-immortalized B cell killing by autologous T and NK cells, is oppositely regulated by c-Myc and EBV latency III program at both mRNA and secretory lysosome levels.
    Durand-Panteix S; Farhat M; Youlyouz-Marfak I; Rouaud P; Ouk-Martin C; David A; Faumont N; Feuillard J; Jayat-Vignoles C
    J Immunol; 2012 Jul; 189(1):181-90. PubMed ID: 22661084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
    Moss DJ; Misko IS; Burrows SR; Burman K; McCarthy R; Sculley TB
    Nature; 1988 Feb; 331(6158):719-21. PubMed ID: 2830541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
    EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.